BACKGROUND: Although the proposal for a dissociative subtype of posttraumatic stress disorder (PTSD) in DSM-5 is supported by considerable clinical and neurobiological evidence, this evidence comes mostly from referred samples in Western countries. Cross-national population epidemiologic surveys were analyzed to evaluate generalizability of the subtype in more diverse samples. METHODS: Interviews were administered to 25,018 respondents in 16 countries in the World Health Organization World Mental Health Surveys. The Composite International Diagnostic Interview was used to assess 12-month DSM-IV PTSD and other common DSM-IV disorders. Items from a checklist of past-month nonspecific psychological distress were used to assess dissociative symptoms of depersonalization and derealization. Differences between PTSD with and without these dissociative symptoms were examined across a variety of domains, including index trauma characteristics, prior trauma history, childhood adversity, sociodemographic characteristics, psychiatric comorbidity, functional impairment, and treatment seeking. RESULTS: Dissociative symptoms were present in 14.4% of respondents with 12-month DSM-IV/Composite International Diagnostic Interview PTSD and did not differ between high and low/middle income countries. Symptoms of dissociation in PTSD were associated with high counts of re-experiencing symptoms and net of these symptom counts with male sex, childhood onset of PTSD, high exposure to prior (to the onset of PTSD) traumatic events and childhood adversities, prior histories of separation anxiety disorder and specific phobia, severe role impairment, and suicidality. CONCLUSION: These results provide community epidemiologic data documenting the value of the dissociative subtype in distinguishing a meaningful proportion of severe and impairing cases of PTSD that have distinct correlates across a diverse set of countries.
BACKGROUND: Although the proposal for a dissociative subtype of posttraumatic stress disorder (PTSD) in DSM-5 is supported by considerable clinical and neurobiological evidence, this evidence comes mostly from referred samples in Western countries. Cross-national population epidemiologic surveys were analyzed to evaluate generalizability of the subtype in more diverse samples. METHODS: Interviews were administered to 25,018 respondents in 16 countries in the World Health Organization World Mental Health Surveys. The Composite International Diagnostic Interview was used to assess 12-month DSM-IV PTSD and other common DSM-IV disorders. Items from a checklist of past-month nonspecific psychological distress were used to assess dissociative symptoms of depersonalization and derealization. Differences between PTSD with and without these dissociative symptoms were examined across a variety of domains, including index trauma characteristics, prior trauma history, childhood adversity, sociodemographic characteristics, psychiatric comorbidity, functional impairment, and treatment seeking. RESULTS: Dissociative symptoms were present in 14.4% of respondents with 12-month DSM-IV/Composite International Diagnostic Interview PTSD and did not differ between high and low/middle income countries. Symptoms of dissociation in PTSD were associated with high counts of re-experiencing symptoms and net of these symptom counts with male sex, childhood onset of PTSD, high exposure to prior (to the onset of PTSD) traumatic events and childhood adversities, prior histories of separation anxiety disorder and specific phobia, severe role impairment, and suicidality. CONCLUSION: These results provide community epidemiologic data documenting the value of the dissociative subtype in distinguishing a meaningful proportion of severe and impairing cases of PTSD that have distinct correlates across a diverse set of countries.
Authors: Matthew J Friedman; Patricia A Resick; Richard A Bryant; James Strain; Mardi Horowitz; David Spiegel Journal: Depress Anxiety Date: 2011-06-16 Impact factor: 6.505
Authors: Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler Journal: Int J Methods Psychiatr Res Date: 2006 Impact factor: 4.035
Authors: Michelle L Munro; Stephanie L Brown; Hossein Pournajafi-Nazarloo; C Sue Carter; William D Lopez; Julia S Seng Journal: J Am Psychiatr Nurses Assoc Date: 2013-06-19 Impact factor: 2.385
Authors: Ruth A Lanius; Jenna E Boyd; Margaret C McKinnon; Andrew A Nicholson; Paul Frewen; Eric Vermetten; Rakesh Jetly; David Spiegel Journal: Curr Psychiatry Rep Date: 2018-11-07 Impact factor: 5.285
Authors: Julia S Seng; Yang Li; James J Yang; Anthony P King; Lisa M Kane Low; Mickey Sperlich; Heather Rowe; Hyunhwa Lee; Maria Muzik; Julian D Ford; Israel Liberzon Journal: J Obstet Gynecol Neonatal Nurs Date: 2017-11-22
Authors: Kristen R Choi; Julia S Seng; Ernestine C Briggs; Michelle L Munro-Kramer; Sandra A Graham-Bermann; Robert C Lee; Julian D Ford Journal: J Am Acad Child Adolesc Psychiatry Date: 2017-10-04 Impact factor: 8.829
Authors: Kristen R Choi; Julian D Ford; Ernestine C Briggs; Michelle L Munro-Kramer; Sandra A Graham-Bermann; Julia S Seng Journal: J Trauma Dissociation Date: 2019-02-04
Authors: Katie A McLaughlin; Karestan C Koenen; Matthew J Friedman; Ayelet Meron Ruscio; Elie G Karam; Victoria Shahly; Dan J Stein; Eric D Hill; Maria Petukhova; Jordi Alonso; Laura Helena Andrade; Matthias C Angermeyer; Guilherme Borges; Giovanni de Girolamo; Ron de Graaf; Koen Demyttenaere; Silvia E Florescu; Maya Mladenova; Jose Posada-Villa; Kate M Scott; Tadashi Takeshima; Ronald C Kessler Journal: Biol Psychiatry Date: 2014-04-12 Impact factor: 13.382
Authors: Christopher D King; Sarah B Hill; Jonathan D Wolff; Cara E Bigony; Sherry Winternitz; Kerry J Ressler; Milissa L Kaufman; Lauren A M Lebois Journal: Psychiatry Res Date: 2020-07-17 Impact factor: 3.222